PD-1 inhibitors induced bullous lichen planus-like reactions: a rare presentation and report of three cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1 inhibitors induced bullous lichen planus-like reactions: a rare presentation and report of three cases

Published:2016-08 Issue:4 Volume:26 Page:421-424
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Wakade Deepal V.,Carlos Giuliana,Hwang Shelley J.E.,Chou Shaun,Hui Rina,Fernandez-Peñas Pablo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference12 articles.

1. PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells;Blank;Cancer Res,2004

2. PD-1 pathway inhibitors: the next generation of immunotherapy for advanced melanoma;Luke;Oncotarget,2015

3. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma;Hamid;N Engl J Med,2013

4. Safety of pembrolizumab for the treatment of melanoma;Martin-Liberal;Expert Opin Drug Saf,2015

5. Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: a single-institution cohort;Hwang;J Am Acad Dermatol,2016

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Hypersensitivity Reactions to Immune Checkpoint Inhibitors;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

2. Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie;Aktuelle Dermatologie;2023-11

3. Molecular Mechanisms of Cutaneous Immune-Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitors;Current Oncology;2023-07-18

4. A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy;Biomedicines;2023-01-24

5. Dermatologic autoimmunity associated with immune checkpoint inhibitors;Translational Autoimmunity;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3